top of page

Produções

Artigos científicos

2026

Predictive value of admission blood glucose for early severity stratification in pediatric scorpion envenomation.

In vivo biodistribution of Loxosceles intermedia venom in animal models with different pathological outcomes.

A review of reported bushmaster (Lachesis spp.) bites in the Americas.

Influence of the ABO system on the hemolytic activity of medically relevant Loxosceles venoms in Brazil.

2025

Development of a neutralizing monoclonal antibody targeting Bothrops atrox venom metalloproteinases.

PepLess: A computational tool developed to optimize SPOT synthesis and analyze related immunoassay data

Functional analyses and integrated mechanisms of cellular destruction by L-amino acid oxidase.

Jelleine-I Membrane Interaction-related Biological Properties and Antimicrobial Activity against MDR, XDR, and PDR-Acinetobacter baumannii Clinical Isolates.

Properties and Pharmacology of Scorpion Toxins and Their Biotechnological Potential in Agriculture and Medicine

2024

Venom from Loxosceles Spiders Collected in Southeastern and Northeastern Brazilian Regions Cause Hemotoxic Effects on Human Blood Components.

Development and evaluation of a recombinant multi-epitopic protein (TsMEP) as an antigen candidate for Tityus serrulatus antivenom production

Divergence in toxin antigenicity and venom enzymes in Tityus melici, a medically important scorpion, despite transcriptomic and phylogenetic affinities with problematic Brazilian species

Protective effects of mesenchymal stromal cell-derived secretome on dermonecrosis induced in rabbits by Loxosceles intermedia spider venom.

Loxosceles amazonica Brown Spider venom: Insights into enzymatic activities, immunorecognition, and novel phospholipase D isoforms.

2023

Toxic and antigenic characterization of Peruvian Micrurus surinamensis coral snake venom

Peruvian Micrurus surinamensis coral snake.png

The C-terminal mutation beyond the catalytic site of brown spider phospholipase D significantly impacts its biological activities

brown spider.png

Partial characterization of Loxosceles anomala (Mello-Leitão, 1917) venom: A brown spider of potential medical concern

Bothrops atrox venom: Biochemical properties and cellular phenotypes of three highly toxic classes of toxins

The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production

Loxosceles amazonica Brown Spider Venom: Insights into Enzymatic Activities, Immunorecognition, and Novel Phospholipase D Isoforms

Protective effects of mesenchymal stromal cell-derived secretome on dermonecrosis induced in rabbits by Loxosceles intermedia spider venom

Simultaneous identification of three clinically relevant peruvian pit vipers by multiplex loop-mediated isothermal amplification (mLAMP)

Comparison of Four Methods of RNA Extraction and cDNA Synthesis from The Venom of Peruvian Snakes of the Genus Bothrops of Clinical Importance

Scorpion envenomation in Brazil: Current scenario and perspectives for containing an increasing health problem

Patentes

Processo para obtenção de proteína recombinante multiepítopo de Loxosceles e uso.
Número do registro: BR020220026866; 2022.

Processo de obtenção de peptídeos analgésicos por meio de Bioinformática e peptídeo obtido.

Número do registro: BR1020220124558; 2022.

Proteína recombinante multiepítopo, kit e método para diagnóstico da Covid-19 e usos.

Número do registro: BR1020220132259; 2022.

Proteina Quimérica Recombinante, DNA e Usos para Produção de Soros antiveneno de Tityus serrulatus.

Número do registro: BR1020230277918; 2023.

Anticorpo monoclonal e uso para produção de composições para neutralizar a atividade hemorrágica de venenos ofídicos.

Número do registro: BR1020250058901; 2025.

Anticorpo monoclonal quimérico, vetor plasmidial, composição farmacêutica para tratamento de envenenamentos por Bothrops spp.

Número do registro: BR1020250294818; 2025.

bottom of page